SIH Partners’s Elevance Health ELV Stock Holding History

SIH Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,294	Closed	-$998K	–	214
2025 Q1	$998K	Buy	+2,294	New	+$921K	0.03%	119

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

SIH Partners's ELV Position: Q2 2025 in Review

SIH Partners sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 2,294 shares — an estimated $998K sold.

SIH Partners first reported a position in ELV in Q1 2025 and held it in 1 quarter. The position peaked at $998K in Q1 2025. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

SIH Partners reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 2,294 Elevance Health shares in Q2 2025, an estimated $998K.
SIH Partners first reported a position in Elevance Health in Q1 2025 and held it in 1 quarter.
SIH Partners's Elevance Health position peaked at $998K in Q1 2025.
1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.